Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
April 9, 2008
Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonists
Lawrence A Reiter, Christopher S Jones, William H Brissette, et al.
Infection Control and Hospital Epidemiology
|
August 27, 2010
Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida
L Silvia Munoz-Price, Carolina De La Cuesta, Stephen Adams, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 18, 2009
5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV
Jeremy T Starr, Richard J Sciotti, Debra L Hanna, et al.
Journal of Medicinal Chemistry
|
April 4, 2014
Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteria
Jeremy Starr, Matthew F Brown, Lisa Aschenbrenner, et al.
British Journal of Sports Medicine
|
October 20, 2018
Impact of prenatal exercise on both prenatal and postnatal anxiety and depressive symptoms: a systematic review and meta-analysis
Margie H Davenport, Ashley P McCurdy, Michelle F Mottola, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 19, 2010
Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor
Amy S Antipas, Laura C Blumberg, William H Brissette, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 15, 2017
Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV
Mark J Mitton-Fry, Steven J Brickner, Judith C Hamel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 2, 2016
New Antimicrobial Agents … but No Susceptibility Tests!
Jane E Ambler, Kevin M Krause, Judith N Steenbergen, et al.
Journal of Medicinal Chemistry
|
November 26, 2010
Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection
Mark E Flanagan, Todd A Blumenkopf, William H Brissette, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 21, 2007
Pyrimidine benzamide-based thrombopoietin receptor agonists
Lawrence A Reiter, Chakrapani Subramanyam, Emilio J Mangual, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Bioorganic & Medicinal Chemistry Letters
|
April 9, 2008
Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonists
Lawrence A Reiter, Christopher S Jones, William H Brissette, et al.
Infection Control and Hospital Epidemiology
|
August 27, 2010
Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida
L Silvia Munoz-Price, Carolina De La Cuesta, Stephen Adams, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 18, 2009
5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV
Jeremy T Starr, Richard J Sciotti, Debra L Hanna, et al.
Journal of Medicinal Chemistry
|
April 4, 2014
Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteria
Jeremy Starr, Matthew F Brown, Lisa Aschenbrenner, et al.
British Journal of Sports Medicine
|
October 20, 2018
Impact of prenatal exercise on both prenatal and postnatal anxiety and depressive symptoms: a systematic review and meta-analysis
Margie H Davenport, Ashley P McCurdy, Michelle F Mottola, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 19, 2010
Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor
Amy S Antipas, Laura C Blumberg, William H Brissette, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 15, 2017
Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV
Mark J Mitton-Fry, Steven J Brickner, Judith C Hamel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 2, 2016
New Antimicrobial Agents … but No Susceptibility Tests!
Jane E Ambler, Kevin M Krause, Judith N Steenbergen, et al.
Journal of Medicinal Chemistry
|
November 26, 2010
Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection
Mark E Flanagan, Todd A Blumenkopf, William H Brissette, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 21, 2007
Pyrimidine benzamide-based thrombopoietin receptor agonists
Lawrence A Reiter, Chakrapani Subramanyam, Emilio J Mangual, et al.
Page
of 6